ODTX Odyssey Therapeutics, Inc.

-

Odyssey Therapeutics Missed Consensus Estimates

Wednesday, August 5, 2026 · 12:00 AM ET

Odyssey Therapeutics (ODTX) reported a loss of $1.26 per share on revenue of $0.00 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.83 per share. The company missed consensus estimates by 51.81%.

Earnings Whisper Grade
Power Rating
Reported Earnings
($1.26)
Earnings Whisper®
Consensus Estimate
($0.83)
Earnings Surprise
Earnings Growth
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth